{"transactions":[{"id":2108827,"issuer":{"id":113211,"kind":"organization","name":"Wejo Group Ltd","symbol":"WEJO"},"owners":[{"id":122234,"kind":"person","name":"Maxwell John T.","position":1,"cik":"0001739025","reported_name":"Maxwell John T.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Shares","published_at":"2022-11-21T16:12:49.000Z","date":"2022-11-19","kind":"tax_withholding","acquired":false,"shares":74456,"price":0.84,"value":62543.04,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents common shares withheld to satisfy tax withholding obligations in connection with the vesting of restricted share units."}],"balance_after":440593,"source":{"system":"sec-edgar","filing":"0001864448-22-000101","document":"wf-form4_166906515194886.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1864448/000186444822000101/wf-form4_166906515194886.xml","form_type":"4"}},{"id":2200390,"issuer":{"id":113211,"kind":"organization","name":"Wejo Group Ltd","symbol":"WEJO"},"owners":[{"id":122234,"kind":"person","name":"Maxwell John T.","position":1,"cik":"0001739025","reported_name":"Maxwell John T.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Warrants (right to buy)","published_at":"2022-07-29T16:18:23.000Z","date":"2022-07-27","kind":"grant","acquired":true,"shares":12252,"price":0.125,"value":1531.5,"ownership":{"direct":false,"nature":"Held by Spouse"},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Warrants purchased from the Company in the Private Placement."}],"balance_after":12252,"derivative":{"exercise_price":1.5643,"exercise_date":"2022-07-29","expiration_date":"2027-07-29","underlying":"Common Shares","underlying_shares":12252},"source":{"system":"sec-edgar","filing":"0001864448-22-000066","document":"wf-form4_165912586017785.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1864448/000186444822000066/wf-form4_165912586017785.xml","form_type":"4"}},{"id":2200389,"issuer":{"id":113211,"kind":"organization","name":"Wejo Group Ltd","symbol":"WEJO"},"owners":[{"id":122234,"kind":"person","name":"Maxwell John T.","position":1,"cik":"0001739025","reported_name":"Maxwell John T.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Warrants (right to buy)","published_at":"2022-07-29T16:18:23.000Z","date":"2022-07-27","kind":"grant","acquired":true,"shares":12252,"price":0.125,"value":1531.5,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Warrants purchased from the Company in the Private Placement."}],"balance_after":12252,"derivative":{"exercise_price":1.5643,"exercise_date":"2022-07-29","expiration_date":"2027-07-29","underlying":"Common Shares","underlying_shares":12252},"source":{"system":"sec-edgar","filing":"0001864448-22-000066","document":"wf-form4_165912586017785.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1864448/000186444822000066/wf-form4_165912586017785.xml","form_type":"4"}},{"id":2200388,"issuer":{"id":113211,"kind":"organization","name":"Wejo Group Ltd","symbol":"WEJO"},"owners":[{"id":122234,"kind":"person","name":"Maxwell John T.","position":1,"cik":"0001739025","reported_name":"Maxwell John T.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Shares","published_at":"2022-07-29T16:18:23.000Z","date":"2022-07-27","kind":"grant","acquired":true,"shares":36757,"price":1.3603,"value":50000.5471,"ownership":{"direct":false,"nature":"Held by Spouse"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Common Shares purchased from Wejo Group Limited (the \"Company\") in a private placement of an aggregate of 11,329,141 of the Company's Units (as defined below), each consisting of (i) one of theCompany's common shares (the \"Shares\") and (ii) one third of one warrant to purchase one Share (the \"Warrants,\" and together with the Shares, the \"Units\") at a purchase price of $1.40197 per Unit (the \"Private Placement\"). The Reporting Person's purchase of the Units was approved by the Company's Board of Directors."}],"balance_after":36757,"source":{"system":"sec-edgar","filing":"0001864448-22-000066","document":"wf-form4_165912586017785.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1864448/000186444822000066/wf-form4_165912586017785.xml","form_type":"4"}},{"id":2200387,"issuer":{"id":113211,"kind":"organization","name":"Wejo Group Ltd","symbol":"WEJO"},"owners":[{"id":122234,"kind":"person","name":"Maxwell John T.","position":1,"cik":"0001739025","reported_name":"Maxwell John T.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Shares","published_at":"2022-07-29T16:18:23.000Z","date":"2022-07-27","kind":"grant","acquired":true,"shares":36757,"price":1.3603,"value":50000.5471,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Common Shares purchased from Wejo Group Limited (the \"Company\") in a private placement of an aggregate of 11,329,141 of the Company's Units (as defined below), each consisting of (i) one of theCompany's common shares (the \"Shares\") and (ii) one third of one warrant to purchase one Share (the \"Warrants,\" and together with the Shares, the \"Units\") at a purchase price of $1.40197 per Unit (the \"Private Placement\"). The Reporting Person's purchase of the Units was approved by the Company's Board of Directors."}],"balance_after":515049,"source":{"system":"sec-edgar","filing":"0001864448-22-000066","document":"wf-form4_165912586017785.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1864448/000186444822000066/wf-form4_165912586017785.xml","form_type":"4"}},{"id":3051969,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":122234,"kind":"person","name":"Maxwell John T.","position":1,"cik":"0001739025","reported_name":"Maxwell John T.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP-Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-08-19T12:55:53.000Z","date":"2020-08-18","kind":"sale","acquired":false,"shares":3000,"price":8,"value":24000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 was effective pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on March 16, 2020."}],"balance_after":150614,"source":{"system":"sec-edgar","filing":"0001214659-20-007366","document":"marketforms-49485.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1398733/000121465920007366/marketforms-49485.xml","form_type":"4"}},{"id":3201957,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":122234,"kind":"person","name":"Maxwell John T.","position":1,"cik":"0001739025","reported_name":"Maxwell John T.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP-Chief Financial Officer"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2020-03-18T20:47:22.000Z","date":"2020-03-16","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The units subject to the Award shall vest 25% 1st year, 25% 2nd year and 50% 3rd year on the commencement anniversaries."}],"balance_after":60000,"derivative":{"exercise_price":1.54,"expiration_date":"2030-03-16","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001214659-20-002751","document":"marketforms-48345.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1398733/000121465920002751/marketforms-48345.xml","form_type":"4"}},{"id":3618007,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":122234,"kind":"person","name":"Maxwell John T.","position":1,"cik":"0001739025","reported_name":"Maxwell John T.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP-Chief Financial Officer"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2019-03-04T21:45:57.000Z","date":"2019-02-28","kind":"grant","acquired":true,"shares":95000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The units subject to the Award shall vest 25% 1st year, 25% 2nd year and 50% 3rd year on the commencement anniversaries."}],"balance_after":95000,"derivative":{"exercise_price":8.05,"expiration_date":"2029-02-28","underlying":"Common Stock","underlying_shares":95000},"source":{"system":"sec-edgar","filing":"0001214659-19-001749","document":"marketforms-44355.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1398733/000121465919001749/marketforms-44355.xml","form_type":"4"}},{"id":3739080,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":122234,"kind":"person","name":"Maxwell John T.","position":1,"cik":"0001739025","reported_name":"Maxwell John T.","relationship":{"officer":true,"officer_title":"SVP-Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-12-07T21:27:58.000Z","date":"2018-12-06","kind":"purchase","acquired":true,"shares":5000,"price":8.87,"value":44350.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Includes 10,000 shares owned jointly with Mr. Maxwell's spouse."}],"balance_after":153614,"source":{"system":"sec-edgar","filing":"0001140361-18-044723","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1398733/000114036118044723/form4.xml","form_type":"4"}},{"id":3752723,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":122234,"kind":"person","name":"Maxwell John T.","position":1,"cik":"0001739025","reported_name":"Maxwell John T.","relationship":{"officer":true,"officer_title":"SVP-Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-11-26T18:39:56.000Z","date":"2018-11-21","kind":"purchase","acquired":true,"shares":10000,"price":9.8,"value":98000.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Includes 10,000 shares owned jointly with Mr. Maxwell's spouse."}],"balance_after":148614,"source":{"system":"sec-edgar","filing":"0001140361-18-043653","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1398733/000114036118043653/form4.xml","form_type":"4"}},{"id":3860694,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":122234,"kind":"person","name":"Maxwell John T.","position":1,"cik":"0001739025","reported_name":"Maxwell John T.","relationship":{"officer":true,"officer_title":"SVP-Chief Financial Officer"}}],"security":"Stock Option (Right to Purchase)","published_at":"2018-07-27T01:12:15.000Z","date":"2018-07-24","kind":"grant","acquired":true,"shares":36120,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the options vest as follows: 25% of the underlying shares vest on the first anniversary of the grant date, 25% of the underlying shares vest on the second anniversary of the grant date and the remaining 50% of the underlying shares vest on the third anniversary of the grant date, subject in each case to Mr. Maxwell's continuous service with the Issuer from the grant date through the applicable vesting date."}],"balance_after":36120,"derivative":{"exercise_price":15,"expiration_date":"2028-07-24","underlying":"Common Stock","underlying_shares":36120},"source":{"system":"sec-edgar","filing":"0001140361-18-033743","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1398733/000114036118033743/form4.xml","form_type":"4"}}]}